Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease

Abstract

Our data indicate that the PXR is a major and clinically relevant antagonist of NF-κB activity in the intestinal epithelial compartment during inflammatory bowel disease.